Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01446029 · ClinicalTrials.gov registry record · Phase 3
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)
A Phase 3 study of Chronic Kidney Disease, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 601
- Enrollment target
- 1
- Study location
NCT01446029 is a Phase 3 study of Chronic Kidney Disease that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 601 participants, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01446029, a Phase 3 study of Chronic Kidney Disease, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 601 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the adoption of a chronic care model in conjunction with tele monitoring and case management can reduce the risk of death, hospitalization, emergency room visits, or admission to a skilled nursing facility in patients with chronic kidney disease compared to usual care.
Conditions Studied
Interventions
- DEVICE Video Telemonitoring Device with Clinical Care Modules
Study Locations (1)
Minnesota
- VA Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01446029
The ClinicalTrials.gov registry entry for NCT01446029 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,201-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (81% lower). The listed sponsor is Minneapolis Veterans Affairs Medical Center, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Video Telemonitoring Device with Clinical Care Modules is the first listed.
NCT01446029 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01446029 about?
NCT01446029 is a clinical study titled "Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)". The purpose of this study is to determine if the adoption of a chronic care model in conjunction with tele monitoring and case management can reduce the risk of death, hospitalization, emergency room visits, or admission to a skilled nursing facility in patients with chronic kidney disease compared ...
What is the current status of trial NCT01446029?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 601 participants. The study started on 2012-03. Estimated completion is 2013-10.
What conditions does trial NCT01446029 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT01446029?
The interventions under investigation include: Video Telemonitoring Device with Clinical Care Modules (DEVICE).
Who is sponsoring clinical trial NCT01446029?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01446029 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
RECRUITING · Phase 3
-
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
RECRUITING · Phase 3
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.